Biocytogen at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Biocytogen brings 4 presentations to ENA 2026 in Barcelona, and exhibits at Booth 23. Its posters pair its own drug candidates with humanized mouse models for preclinical testing. The candidates are BCG040, a biparatopic ADC targeting B7-H4, and BCG024, a DLL3×CD3×4-1BB trispecific T cell engager, while the models include B-hCRBN mice for PROTAC studies.

Organization	ENA 2026 Attendance
Biocytogen Beijing, China
biocytogen.com CROs & CDMOsExhibitor Provides humanized mouse models, preclinical pharmacology and antibody discovery, and develops its own antibody and ADC candidates.	Booth Exhibiting at Booth 23 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Part of Poster session: Antibody-drug conjugates BCG040, a Novel B7-H4-Targeting Biparatopic ADC, Demonstrates Superior Preclinical Efficacy in Heterogeneous Tumors ADCs & radioligands Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Part of Poster session: New therapies in immuno oncology BCG024: A Novel DLL3×CD3×4-1BB Trispecific T Cell Engager Enhances T Cell Persistence and Functionality in Preclinical Models Immuno-oncology Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Animal Models The B-hCRBN Mice Model Facilitates PROTACs Studies Based on CRBN Ligands Preclinical models Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Animal Models Utilizing a Humanized CD8 Mouse Model for Non-clinical Studies of Cancer Immunotherapy Preclinical models

Organization

ENA 2026 Attendance

Biocytogen

Beijing, China

biocytogen.com

CROs & CDMOsExhibitor

Provides humanized mouse models, preclinical pharmacology and antibody discovery, and develops its own antibody and ADC candidates.

Booth

Exhibiting at Booth 23

Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm

Poster

Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm